ThomasWilliamFerkolJr.MD

Alexis Hartmann Professor of Pediatrics Professor of Cell Biology and Physiology

Dr. Ferkol is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 Manning Dr
Chapel Hill, NC 27514
Phone+1 919-966-1505

Fax+1 314-454-2515

Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Pediatric Pulmonology, 1989 - 1992
University of North Carolina HospitalsResidency, Pediatrics, 1985 - 1989
Ohio State University College of MedicineClass of 1985

PubMed

5 citations
Laterality Defects in Primary Ciliary Dyskinesia: Relationship to Ultrastructural Defect or Genotype.
Andrew T Barber, Adam J Shapiro, Stephanie D Davis, Thomas W Ferkol, Jeffrey J Atkinson
Annals of the American Thoracic Society. 2023-03-01
27 citations
Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium
Rita M. Ryan, Roberta L. Keller, Brenda B. Poindexter, Carl T. D'Angio, Pamela A. Shaw
The Journal of Pediatrics. 2019-05-01
4 citations
Prevention of cystic fibrosis: The beginning of the end?
Thomas W. Ferkol
Science Translational Medicine. 2019-03-27

Journal Articles

Early Diagnosis and Intervention in Cystic Fibrosis: Imagining the Unimaginable
Andrea M Coverstone, Thomas W Ferkol, Frontiers in Pediatric Pulmonology
Electronic Cigarette Use in Youths: A Position Statement of the Forum of International Respiratory Societies
Dean E Schraufnagel, Thomas W Ferkol, Frank T Leone, Harold J Farber, Enid Neptune, The European Respiratory Journal

Consortium Spotlight: Advancing Discoveries in Mucociliary Clearance DiseasesMarch 11th, 2022
New Drug Appears to Slow Effects of Cystic Fibrosis, Offering Hope to Long-Suffering PatientsDecember 18th, 2019
NIH Awards $7.5 Million to Ramp up Clinical Trials for Rare, Genetic Airway DiseasesOctober 9th, 2019
Join now to see all

Genetic Disorders of the Mucociliary Clearance ConsortiumOffice of Rare Disease Research/National Heart Lung and Blood Institute2004–2024
Influence Of The Enteric Microbiome On The Genesis Of Bronchopulmonary DysplasiaNational Heart, Lung, And Blood Institute2010–2012
Delivering Antiproteases To The Bronchiectatic AirwayNational Heart, Lung, And Blood Institute2006–2009
Longitudinal Study Of Primary Ciliary Dyskinesia (Pcd Study)National Center For Research Resources2007
Diagnostic And Clinical Characterization Of Patients With Unusual Genetic DISNational Center For Research Resources2007
Genetic Variants Of Primary Ciliary DyskinesiaNational Heart, Lung, And Blood Institute2005–2006
Genetic Modifiers Of Cystic FibrosisNational Center For Research Resources2004
Targeted Delivery Of Interleukin-10National Heart, Lung, And Blood Institute2001–2004
Targeting Proteins To The Respiratory Epithelial SurfaceNational Heart, Lung, And Blood Institute1998–2002
Gene Transfer Into Respiratory Tract In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1998